Vicore webcast: Buloxibutid and the Evolving IPF Landscape

Registrering

Back to news

Read more posts

  • Science

    • Related posts

    Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

    C21 shows promise against COVID-19 where other drugs have failed

    MedNous article: A surprise finding in the clinic

    Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

    Report on the ATTRACT study